Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Priori

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Pacing and Clinical Electrophysiology : PACE|February 24, 2001
Inferior vena cava loop of the implantable cardioverter defibrillator endocardial lead: a possible solution of the growth problem in pediatric implantationM Gasparini, M Mantica, P Galimberti, et al.
Circulation|August 30, 2000
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challengeS G Priori, C Napolitano, P J Schwartz, et al.
American Heart Journal|June 1, 1989
Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-upM Facchini, T Varisco, O Bonazzi, et al.
European Heart Journal|May 1, 1988
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmiasM Facchini, O Bonazzi, S G Priori, et al.
Cardiovascular Drugs and Therapy|February 1, 1991
Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardiumK A Yamada, D J Dobmeyer, E M Kanter, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 20, 2001
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]M Cerrone, L Crotti, G Faggiano, et al.
Journal of the American College of Cardiology|June 1, 1995
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agentsE Vanoli, S G Priori, H Nakagawa, et al.
Circulation|February 24, 2001
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardiaS G Priori, C Napolitano, N Tiso, et al.
Journal of Cardiovascular Electrophysiology|June 27, 2000
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmiasC Napolitano, P J Schwartz, A M Brown, et al.
Circulation|December 31, 1997
Evaluation of the spatial aspects of T-wave complexity in the long-QT syndromeS G Priori, D W Mortara, C Napolitano, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Pacing and Clinical Electrophysiology : PACE|February 24, 2001
Inferior vena cava loop of the implantable cardioverter defibrillator endocardial lead: a possible solution of the growth problem in pediatric implantationM Gasparini, M Mantica, P Galimberti, et al.
Circulation|August 30, 2000
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challengeS G Priori, C Napolitano, P J Schwartz, et al.
American Heart Journal|June 1, 1989
Efficacy and safety of flecainide in low-risk patients with chronic ventricular arrhythmias: a two-year follow-upM Facchini, T Varisco, O Bonazzi, et al.
European Heart Journal|May 1, 1988
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmiasM Facchini, O Bonazzi, S G Priori, et al.
Cardiovascular Drugs and Therapy|February 1, 1991
Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardiumK A Yamada, D J Dobmeyer, E M Kanter, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|April 20, 2001
[Long QT syndrome and Brugada syndrome: 2 aspects of the same disease?]M Cerrone, L Crotti, G Faggiano, et al.
Journal of the American College of Cardiology|June 1, 1995
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agentsE Vanoli, S G Priori, H Nakagawa, et al.
Circulation|February 24, 2001
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardiaS G Priori, C Napolitano, N Tiso, et al.
Journal of Cardiovascular Electrophysiology|June 27, 2000
Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmiasC Napolitano, P J Schwartz, A M Brown, et al.
Circulation|December 31, 1997
Evaluation of the spatial aspects of T-wave complexity in the long-QT syndromeS G Priori, D W Mortara, C Napolitano, et al.
Pageof 9